Categorizing some early and late transcripts directed by the Autographa californica nuclear polyhedrosis virus.
Using an S1 mapping assay on RNA from Spodoptera frugiperda cells infected by the Autographa californica nuclear polyhedrosis virus in the presence and absence of cycloheximide and aphidicolin, we can distinguish three classes of transcripts. First, there are those whose synthesis is blocked by the DNA synthesis inhibitor aphidicolin and which are therefore late transcripts. These include the late transcript of the 39K gene and a late leftward transcript across the XhoI site in the HindIII-F region. Second, there are those whose synthesis is not blocked by aphidicolin, but whose accumulation is inhibited by the protein synthesis inhibitor cycloheximide and which are therefore presumably delayed early genes. These include the p26 transcript(s), the early 39K transcript and the alpha 2 transcript in the HindIII-K/Q region. Third, there are those whose accumulation is not affected or is enhanced by cycloheximide. These are not necessarily immediate early transcripts, but their response to cycloheximide is clearly different from that of those in the second class. They include the alpha 1 and alpha 3 transcripts in the HindIII-K/Q region and the early leftward transcript across the XhoI site in the HindIII-F region.
Huh
N E
NE
Department of Biochemistry, University of Kansas, Lawrence 66045.
Weaver
R F
RF
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D016590:Aphidicolin; D003513:Cycloheximide / Q000494:pharmacology; D004224:Diterpenes / Q000494:pharmacology; D015870:Gene Expression / Q000187:drug effects; D005814:Genes, Viral / Q000187:drug effects; D007304:Insect Viruses / Q000187:drug effects / Q000235:genetics*; D009036:Moths; D011061:Poly A / Q000235:genetics / Q000302:isolation & purification; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D012333:RNA, Messenger; D012367:RNA, Viral / Q000235:genetics / Q000302:isolation & purification; D015183:Restriction Mapping; D014158:Transcription, Genetic / Q000187:drug effects; D014764:Viral Proteins / Q000235:genetics*
D000998:Antiviral Agents; D004224:Diterpenes; D012333:RNA, Messenger; D012367:RNA, Viral; D014764:Viral Proteins; D011061:Poly A; D016590:Aphidicolin; D012313:RNA; D003513:Cycloheximide